Barcelona, Spain

Mario Colombo Piñol

This inventor holds 1 USPTO granted patent. Top assignee: Laboratorios Del Dr. Esteve S.a.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mario Colombo Piñol. Retrieved from https://idiyas.com/inventor/mario-colombo-piñol

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mario Colombo Piñol

Introduction

Mario Colombo Piñol is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrazoline derivatives. His research focuses on developing therapeutic agents that can provide relief from inflammation and pain.

Latest Patents

Mario Colombo Piñol holds a patent for "Derivatives of pyrazoline, procedure for obtaining them and use thereof as therapeutic agents." This invention relates to derivatives of a specific general formula and includes their pharmaceutically acceptable salts, stereoisomeric forms, and N-oxides. The derivatives are particularly useful as anti-inflammatory and analgesic agents, showcasing their potential in medical applications.

Career Highlights

Throughout his career, Mario has been associated with Laboratorios Del Dr. Esteve S.A., where he has contributed to various research projects. His work has been instrumental in advancing the understanding of pyrazoline compounds and their therapeutic uses.

Collaborations

Mario has collaborated with several professionals in his field, including Rosa Cuberes Altisen and Mercedes Port De Pol. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Mario Colombo Piñol's innovative work in the pharmaceutical industry highlights the importance of research in developing new therapeutic agents. His contributions continue to influence the field and offer hope for effective treatments in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…